SEPRACOR PHARMACEUTICALS INC - search_results

Իսրայել - եբրայերեն - Ministry of Health

נובוסבן אר.טי 1 מג בקבוקון

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 1 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Իսրայել - եբրայերեն - Ministry of Health

נובוסבן אר.טי 2 מג בקבוקון

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Իսրայել - եբրայերեն - Ministry of Health

נובוסבן אר.טי 5 מג בקבוקון

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 5 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

Իսրայել - եբրայերեն - Ministry of Health

retractors and surgical holders

כמיטק בע""מ - רופא - ציוד כירורגי לבתי חולים

Իսրայել - եբրայերեն - Ministry of Health

retractor, surgical holders & laparoscopic instrumentations non disposable and disposable

כמיטק - רופא - ציוד כירורגי לבתי חולים

Իսրայել - եբրայերեն - Ministry of Health

heart valve retractor and accessories

גאמידה בע"מ - רופא - מרחיב לבית החזה

Իսրայել - եբրայերեն - Ministry of Health

mediflex, retractors and surgical holders, class ii, islandia

כמיטק בע""מ - רופא - ציוד כירורגי לבתי חולים